2021
DOI: 10.1016/j.ghir.2020.101362
|View full text |Cite
|
Sign up to set email alerts
|

Endothelial dysfunction in patients with acromegaly and It's association with Endocan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 44 publications
0
1
0
Order By: Relevance
“…In acromegaly, the mechanisms underlying this effect could be an imbalance between endothelium derived vasodilators (particularly NO) and ROS, together with increase of blood pressure, insulin and lipid profile values[ 91 , 92 ]. Along with these risk factors, GH and insulin-like growth factor-1 (IGF-1) can directly cause changes in macrovascular structures by vasoconstriction IGF-1 mediated via the nitric oxide synthesis or damage to vascular smooth muscle cells[ 93 ].…”
Section: Endothelial Impairment In Pituitary Dysfunctionmentioning
confidence: 99%
“…In acromegaly, the mechanisms underlying this effect could be an imbalance between endothelium derived vasodilators (particularly NO) and ROS, together with increase of blood pressure, insulin and lipid profile values[ 91 , 92 ]. Along with these risk factors, GH and insulin-like growth factor-1 (IGF-1) can directly cause changes in macrovascular structures by vasoconstriction IGF-1 mediated via the nitric oxide synthesis or damage to vascular smooth muscle cells[ 93 ].…”
Section: Endothelial Impairment In Pituitary Dysfunctionmentioning
confidence: 99%